Correlation Between Olema Pharmaceuticals and MAIA Biotechnology
Can any of the company-specific risk be diversified away by investing in both Olema Pharmaceuticals and MAIA Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Olema Pharmaceuticals and MAIA Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Olema Pharmaceuticals and MAIA Biotechnology, you can compare the effects of market volatilities on Olema Pharmaceuticals and MAIA Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Olema Pharmaceuticals with a short position of MAIA Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Olema Pharmaceuticals and MAIA Biotechnology.
Diversification Opportunities for Olema Pharmaceuticals and MAIA Biotechnology
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Olema and MAIA is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Olema Pharmaceuticals and MAIA Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MAIA Biotechnology and Olema Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Olema Pharmaceuticals are associated (or correlated) with MAIA Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MAIA Biotechnology has no effect on the direction of Olema Pharmaceuticals i.e., Olema Pharmaceuticals and MAIA Biotechnology go up and down completely randomly.
Pair Corralation between Olema Pharmaceuticals and MAIA Biotechnology
Given the investment horizon of 90 days Olema Pharmaceuticals is expected to generate 1.01 times more return on investment than MAIA Biotechnology. However, Olema Pharmaceuticals is 1.01 times more volatile than MAIA Biotechnology. It trades about 0.06 of its potential returns per unit of risk. MAIA Biotechnology is currently generating about -0.13 per unit of risk. If you would invest 589.00 in Olema Pharmaceuticals on November 4, 2024 and sell it today you would earn a total of 22.00 from holding Olema Pharmaceuticals or generate 3.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Olema Pharmaceuticals vs. MAIA Biotechnology
Performance |
| Timeline |
| Olema Pharmaceuticals |
| MAIA Biotechnology |
Olema Pharmaceuticals and MAIA Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Olema Pharmaceuticals and MAIA Biotechnology
The main advantage of trading using opposite Olema Pharmaceuticals and MAIA Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Olema Pharmaceuticals position performs unexpectedly, MAIA Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MAIA Biotechnology will offset losses from the drop in MAIA Biotechnology's long position.| Olema Pharmaceuticals vs. Sana Biotechnology | Olema Pharmaceuticals vs. Cullinan Oncology LLC | Olema Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Olema Pharmaceuticals vs. Molecular Partners AG |
| MAIA Biotechnology vs. Lineage Cell Therapeutics | MAIA Biotechnology vs. Armata Pharmaceuticals | MAIA Biotechnology vs. Portage Biotech | MAIA Biotechnology vs. Larimar Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |